AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (263.9 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Measure of Innovation: From Clinical Questions to Actionable Evidence

Shouzheng Wang1 , Fei Ma2 ( )
State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Department of Medical Oncology, State Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Innovative Drug Research and Translational Study for Breast Cancer, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Show Author Information

References

【1】
【1】
 
 
Cancer Innovation
Article number: e70086

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Wang S, Ma F. Measure of Innovation: From Clinical Questions to Actionable Evidence. Cancer Innovation, 2026, 5(5): e70086. https://doi.org/10.1002/cai2.70086

8

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 23 September 2026
Accepted: 30 September 2026
Published: 14 October 2026
© 2026 The Author(s). Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.